Back to search results
NCT06810973

Substance Use and HIV Action for Reentry and Engagement.

Enrolling by Invitation
NAAges 18+InterventionalSupportive care
Emory University
~100 participants
Updated 2025-08-11 on ClinicalTrials.gov
What's tested:SUCCESS-EEnhanced Standard of CareKey Informant Interviews

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Linkage to ART
Measured over 3 months
+1 more outcome measured

Conditions

HIV

Explore related trials

HIV Infection

Where it's being run

1 sites across 1 states
Georgia1

Study leadership

  • Anne Spaulding, MD, MPH · PRINCIPAL_INVESTIGATOR · Emory University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Cis- and transgender men and women
Able to understand and give informed consent
Willing to participate in study activities
People with HIV (PWH) or people at high risk of seroconversion (PHRS)
History of SUD, defined as a score of 2 or more items in the past year on the Justice Community Opioid Innovation Network (JCOIN) SUD assessment tool
Resident of study jail and agree to participate in the SUCCESS-E program, or released from study jail within six weeks, and agree to participate in the SUCCESS-E program
Participant who completed the intervention or
A jail administrator/staff member
Able to give informed consent
Willing to participate in study activities

Exclusion

Uncontrolled serious mental illness or moderate to severe intellectual impairment, and/or cognitive impairment (inability to comprehend the informed consent document as assessed by study staff during enrollment)
Admission to a prison facility (Federal or state)

What this trial measures

  • Linkage to ART3 months

    Linkage to ART care for individuals with lived experience of HIV or PrEP for PHRS.

  • Program Retention3 months

    Program Retention at 3 months